Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

Benzinga

Clinics now allowed to purchase, prescribe antiviral drugs

The Food and Drug Administration has given the green light for clinics to purchase and prescribe molnupiravir and other antiviral drugs for Covid-19 patients.

Bangkok Post

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Experts still torn on throat swabbing

Other countries' health bureaus have advised the public to throat-swab when taking at-home tests, but not the US

Salon

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

Chicago Tribune

How canine heart disease was tied to grain-free dog food

In 2018, the FDA began investigating whether the increasing popularity of grain-free dog foods had led to a sudden rise in a potentially fatal heart disease in dogs

The Independent UK

The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Get fourth COVID booster now, or wait? CDC says get the shot now, but many hesitate

About 70% of Americans 50 and older who got a first booster shot — and nearly as many of those 65 and older — haven’t gotten their second booster dose, the CDC says.

Chicago Sun-Times

Skittles "unfit" for humans: lawsuit

When Americans eat Skittles, are they tasting more than just the rainbow?

Salon

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

Benzinga

FDA weighs oversight changes after Juul, formula troubles

The head of the Food and Drug Administration is commissioning an independent review of the agency’s food and tobacco programs

The Independent UK

IBD Stock Of The Day Incyte Nears Buy Point After Winning A First-Ever Approval

IBD Stock Of The Day Incyte just won U.S. approval for a new skin treatment, leading Incyte stock to flirt with a breakout.

Investors Business Daily

Is Novavax a Buy, Sell, or Hold Following FDA Decision?

Despite the FDA authorization of Novavax’s (NVAX) two-dose vaccine, the possible side effects and slow vaccine uptake keep the stock under pressure. So, let’s evaluate if it is worth adding the stock to one’s portfolio now. Read on….

StockNews.com

Apellis Surges And Breaks Out As FDA Mulls Its Eye-Disease Treatment

The FDA accepted Apellis Pharmaceuticals' application for an eye-disease treatment on Tuesday, leading APLS stock to surge.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Tribune News Service

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget COVID-19, monkeypox and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

Daily Mirror

Do Covid tests work in the heatwave – and should you put them in the fridge?

Lateral flow tests might not be as effective in the record-breaking temperatures unless users take action before using the do-it-yourself swabs

Los Angeles Times

Skittles ‘unfit for human consumption,’ California lawsuit claims

Skittles, the colorful, fruit-flavored candy, are coming under fire after a lawsuit filed in Northern California says people are tasting more than the rainbow.

Get all your
news in one place.

100’s of premium titles.
One news app.

Reason

Return of Summer Security Theater? Also, Abolish the FDA.

Plus: The editors select their most influential post-war libertarian thinkers.

Investors Business Daily

IBD 50 Stocks To Buy And Watch: Gene Therapy Leader Gains On New Data, Potential FDA Approval

Sarepta is building a base as this biotech stock tries to convince regulators to approve its gene therapy.

Tribune News Service

On Nutrition: Sorting the facts

I have a very nice patient who comes to appointments with questions about everything except his main medical problem. These are from his last visit:

The Street

Can This Small-Cap Biotech 5x Revenue by 2026?

It has one product on the market and up to four more launching by the end of 2023. The growth trajectory depends on execution.

The Independent UK

Candy giant Mars is sued by California man claiming Skittles contain dangerous toxin

‘Our use of titanium dioxide complies with FDA regulations,’ Mars says

Tribune News Service

When Massachusetts tried to ban an opioid, a court said no. What about abortion pills?

WASHINGTON — Efforts in states to further restrict medication abortion face legal questions over potential conflicts with federal drug regulations.

Benzinga

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 123 124 125 126

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Public Health Ministry

434 stories

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.